Chicago Rheumitology-Medical entered the industry of Medical Centers in 2012 and has grown to employ 1 to 4 people, generating an annual revenue of $1.000.000 to $2.499.999. The NAICS classifies this business under the code 6214930, which describes it as a Medical Centers. For further clarification, the SIC classifies this business under the code 8011 and described it as a Medical Centers. The business provides service to the B2C market.
To acquire more information, please contact Dorothy Bloniarz by calling (773) 283-5700 during business hours. You can also write to the business’ Single Location at 5325 West Belmont Avenue, Chicago, Illinois IL 60641. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Chicago Rheumitology-Medical |
| Representative: | Dorothy Bloniarz |
| Place of Business: | 5325 West Belmont Avenue, Chicago, IL 60641 |
| Contact Number: | (773) 283-5700 |
| Type of Service: | Medical Centers |
| SIC Number: | 8011 |
| NAICS Number: | 6214930 |
| Locality: | Single Location |
| Market Type: | B2C (Business to Consumer) |
| Began: | 2012 |
| Income/Year: | $1.000.000 to $2.499.999 |
| Laborers: | 1 to 4 |
| Share This Company: |
Chicago Rheumitology-Medical is a company operating from Cook, Illinois providing professional Medical Centers and relevant B2C variables. It was founded in 2012 and registered with the SIC code 8011 as Medical Centers, and with the NAICS code 6214930 as Medical Centers.
With a current employee count of 1 to 4, Chicago Rheumitology-Medical has gone to report making $1.000.000 to $2.499.999 per annum on its journey towards growth. This company invites you to contact its representative Dorothy Bloniarz at (773) 283-5700 for related queries, or to locate its Single Location using the coordinates 41.938569,-87.760066.
The Single Location can also be found at the street address 5325 West Belmont Avenue in Chicago, Illinois 60641 and can be engaged online through the company website at , the company Twitter , and Facebook page .